key: cord-0926147-pjncoz2n
authors: Garzotto, Francesco; Comoretto, Rosanna Irene; Ostermann, Marlies; Nalesso, Federico; Gregori, Dario; Bonavina, Maria Giuseppina; Zanardo, Giorgio; Meneghesso, Gaudenzio
title: Preventing infectious diseases in Intensive Care Unit by medical devices remote control: Learnings from COVID-19
date: 2020-10-27
journal: J Crit Care
DOI: 10.1016/j.jcrc.2020.10.014
sha: 52e20e6290755a549ac85ecb60f07a93c67a9d2b
doc_id: 926147
cord_uid: pjncoz2n

The management of COVID-19 patients in the ICUs requires several and prolonged life-support systems (mechanical ventilation, continuous infusions of medications and nutrition, renal replacement therapy). Parameters have to be entered continuously into the device user interface by healthcare personnel according to the dynamic clinical conditions. This leads to an increased risk of cross-contamination, use of personal protective equipment and the need for stringent and demanding protocols. Cables and tubing extensions have been utilized to make certain devices usable outside the patient's room but at the cost of introducing further hazards. Remote control of these devices decreases the frequency of unnecessary interventions and reduces the risk of exposure for both patients and healthcare personnel.

CoV-2 virus quickly spread globally killing more than one million people to date, despite important containment measures taken by the 210 most affected countries [1] .

Even though we constantly face infectious diseases, this one seems very contagious, forcing healthcare workers to take strict precautionary measures to prevent hospital crosscontaminations, particularly when looking after critically ill patients with confirmed or suspected COVID-19 [2] . In an early report [3] , 41% of hospitalized COVID-19 cases had additional hospitalacquired infections including patients who were hospitalized for other pathologies and healthcare workers. They represent 3.8% of the 44.672 confirmed cases described by the Chinese Center for Disease Control and Prevention [4] while during the SARS epidemic this percentage rose to 51.8% [5] . There are several important contributing factors: first, the proximity and duration of contact with infected patients, and second, the high risk of exposure to aerosol-generating procedures, especially endotracheal intubation and ventilation. Furthermore, transmission from an infected (and potentially asymptomatic) healthcare worker to patients can occur through respiratory droplets, aerosol and physical contact. As SARS-CoV-2 seems to be able to spread quickly, the issue of healthcare-associated Infections (HAI) is particularly important. Respiratory viral HAIs are already known to be a serious problem, and viral surveillance screening programs [6] are increasing, especially in high-risk areas such as Intensive Care Units (ICUs), bone marrow transplant and oncology wards [7] . In addition to viruses, bacteria present in the environment can be an important source of infections, typically associated with medical devices, such as vascular catheters or ventilators. This element becomes even more serious and important in the case of Multi-Drug Resistant Organisms (MDRO). It has been reported that, despite protocols to prevent contamination which are shared by the prevention controls units of all the countries, HAIs affect approximately 1.7 million patients annually in the US and 8.3% of patients admitted to ICU for more than 48 hours in Europe [8] . Moreover, HAIs are well known to be associated with increased costs, longer length of stay and higher mortality rates [6] .

The management of Covid-19 patients in the ICU requires the use of several different life-support systems, often for a prolonged period. In severe cases, Covid-19 may be complicated by acute J o u r n a l P r e -p r o o f Journal Pre-proof respiratory disease syndrome (ARDS), sepsis and septic shock, multiorgan failure, including acute kidney injury (AKI) and cardiac failure. Patients are cared for in ICU facilities equipped with ventilators and accessories, vital signs monitoring systems and syringe pumps for nutrition, drugs and fluid administration. In addition, Renal Replacement Therapy (RRT) machines for management of AKI and fluid overload [9] and extracorporeal membrane oxygenation may be required. The utilisation of these devices can be challenging, especially in a biohazard environment, as regular adjustment of various different parameters by healthcare personnel is often required. This increases the risk of cross-contamination due to aerosol, infected organic fluids or direct contact with the contaminated device panel [10, 11] . To mitigate these risks and to reduce the consumption of personal protective equipment (PPE) [12] , a group of anaesthesiologists recently connected cable extensions in order to make ventilators' control panel usable outside patients' rooms. Some suppliers have made these cables available as accessories. They have also been approved by regulatory agencies. Site assessments and independent double checks have been agreed according to local procedures (e.g. attaching the patient's barcode in an accessible location for scanning). Moreover, extension tubing sets have been integrated into infusion pumps and RRT machine lines, at the cost of introducing further hazards as described by a UK Government alert [13] . In the current crisis, the risks and benefits [14] need to be re-assessed and any action aimed to guarantee patient safety [15] should be taken immediately. A step forward in managing medical devices in an emergency setting (but not only then), where patients and medical equipment are exposed to viral and bacterial cross-contamination [16] , is the use of remote-control systems to avoid bio-hazardous actions. For the same reason, the FDA reconsidered the benefits/risks of remote control systems and allowed expanded use of devices to monitor patients' vital signs remotely [17] . Nowadays, the data from several medical devices are steadily collected, displayed remotely, analysed and stored using real-time monitoring software. Advantages of remote control use and monitoring have already been reported in home peritoneal dialysis, including updating the prescription of personalized therapies [18] . Furthermore, an improvement in health-related quality of life has been shown in patients with remote control of pacemaker settings [19] .

Although there was some initial resistance to the introduction in clinical practice, all these systems are currently viewed as essential, both in hospital and in-home settings. At this point in time, communication between a remote station and the devices placed in the patient's room is not only technologically possible but essential in many areas ( Figure 1 ). It also reduces unnecessary and frequent biohazard exposure of personnel and limits physical contacts between patients and J o u r n a l P r e -p r o o f healthcare workers. Furthermore, the need for PPE is reduced which contributes to time and cost savings.

Here, we propose a minimum set of parameters needed for a basic remote-control device.

Focusing on a CRRT device, we suggest that blood flow rate (Q B ), net ultrafiltration flowrate (Q NET UF ), dialysate (Q D ) and replacement flow rates (Q R PRE , Q R POST ) and anticoagulant infusion can be remotely controlled ( Figure 1 ). In case of regional anticoagulation, the citrate dose and calcium compensation variation shall be allowed in order to maintain systemic and post-filter ionized calcium in the correct range, according to local protocols [20] . Importantly, monitoring of continuous circuit pressures ( Figure 2 ) [21] , such as the inflow and outflow, pre-and post-filter and effluent pressure, has potential to prevent premature filter clotting and catheter-related (Table 3) , certain parameters need to be set and adjusted, such as the ventilation mode (volume, pressure or dual) and the modality (controlled, assisted, support ventilation). In addition, several respiratory parameters are collected: tidal volume, minute volume in volume modalities, peak pressure, respiratory frequency, positive end expiratory pressure, inspiratory time, inspiratory flow, inspiratory-to-expiratory ratio, time of pause, trigger sensitivity, support pressure, and expiratory trigger sensitivity. A minimum set of parameters for both volume and pressure control are reported in Table 2 . Alarms and monitoring for tidal and minute volume, peak pressure, plateau pressure, respiratory rate, FiO 2 , and apnea must be adjustable [23, 24] .

Regarding drug and fluid administration, infusion pumps require the flow rate to be set. Although most infusion pumps administer fluids in millilitres per hour (ml/h), a volumetric flow, some can be programmed to administer in milligrams per kg per hour (mcg/kg/min), a mass flow.

Techniques exist to assess and monitor the pressures generated within the pump.

The care of ICU patients can be complex, involving different multidisciplinary teams and many medications. In addition, decisions often need to be made quickly. To ensure patient safety in this complex clinical setting, a wide range of actions is necessary to deliver care, facilitate appropriate use of devices, prevent infections, ensure safe drug prescribing and promote a safe working environment [15, 25] .

It is extremely useful for healthcare workers to have all clinical information available in one place when making a decision. The implementation of a unique scalable platform [26] to support several devices and IT services simultaneously would be an optimal solution. At present, there are several potential options in the ICU, from simple data exchange to bidirectional communication with monitors. In general, these solutions require customization that also involves support from hospital IT services, especially when devices of different brands need to be connected.

The lack of interoperability between medical devices can lead to preventable medical errors and potentially serious inefficiencies [25] . Looking at future implementations, a feasibility study in healthy pigs has already been conducted utilizing a fully automated life support system [26] .

Existing frameworks focus predominantly on reducing workload but several other aspects may improve, too, including patient safety and prevention of infections. [14] . If standards are essential for effective technology interoperability, human communication is equally relevant and highly considered in the emerging field of human factors analyses [29] . To define common terminology and color-coding, thus reducing user errors, the nomenclature related to RRT [30, 31] has been agreed as mentioned above.

We recently raised several points for consideration related to Continuous Renal Replacement Therapy (CRRT) and relevant therapies beyond 2027 [32] . to control the device in the same clinical unit where the patient is treated. With the introduction of 5G, the short time required for a set of data to travel between two points (latency) will allow for safer remote control. In the immediate future, a local connection can be chosen, thus avoiding the need to open to a "public" and less secure (for both stability and cybersecurity) public network.

Remote desktop applications, often utilized for remote assistance, are widely available and may represent an easier and more effective way to allow remote control of devices during the COVID-19 emergency. In this case, the graphical user interface (GUI) of the device can allow full control.

This can be viewed as a software alternative to the user interface extension cable. In this way, a human intervention can be actioned immediately. Thus, mitigating both the probability of failure and the harm from a bio-hazard, the overall risk related to caring for a COVID-19 patient is reduced.

To ensure an appropriate level of safety and to prevent accidental changes, a "remote modality"

should be set at the beginning of any new treatment while the user interface should always be password protected. Lastly, in order to preserve and improve patient safety, medical prescriptions and all devices should be linked to one patient only (e.g. through radio-frequency identification wristbands), thus avoiding drug errors.

From a regulatory point of view, devices "shall be safe and effective and shall not compromise the clinical condition or the safety of patients, or the safety and health of users…" and"…any risks which may be associated with their use constitute acceptable risks when weighed against the benefits to the patient…" [33] . Thus, it is necessary to take into account the associated risks and biohazards of multiple extension lines when placing devices outside the patient's room, as highlighted by several suppliers of infusion pumps and RRT devices in specific field safety notices [34, 35] and a recent UK Government Alert [13] . Flow rate may also be impacted by a higher resistance to flow due to longer tubing. Its internal diameter, the length and the materials are within the fluid viscosity variables that impact on the phenomena magnitude. Furthermore, pressure monitoring, disconnections or catheter related problems may not be revealed which contributes further to the risks for the patients.

The implementation of such a system capable of modifying the settings of a device during treatment requires an analysis of all risks, further validation, submission to a regulatory agency (notified bodies in Europe) and, once approved, an official launch. This process which is mandatory J o u r n a l P r e -p r o o f for all medical software, is usually long; however, approval may be accelerated in exceptional circumstances, for instance in response to the COVID-19 pandemic [36] . The U.S. Food and Drug Administration (FDA) has already issued Emergency Use Authorizations (EUA) for various diagnostic, therapeutic, and protective medical devices including ventilators, infusion pumps and extracorporeal blood purification systems. Furthermore the FDA has allowed medical device suppliers to make changes to existing products, such as changes to devices or materials, in an easier way [37] .

In a critical care setting, direct patient monitoring and patient interaction are key elements of clinical practice. However, the frequency of these interactions should be re-evaluated in particular circumstances, such as in high biological risk situations. Device-associated HAIs pose a severe threat to patients, although many advances have been made in the field of prevention that have led to a significant risk reduction.

Similar to other pandemics, we have learnt from Covid-19 outbreaks that the virus can spread quickly among patients and medical personnel. In these critical settings, preventing transmission of infections and protecting healthcare workers should be priority in order to preserve medical personnel resources and achieve patient safety. 

Example of implementation of remote control and monitoring in an ICU setting. The control panel, located in a separate control room, is connected to the devices (RRT in the current image). Modification of parameters can be undertaken by medical personnel, without the need to enter the patient's room.

Coronavirus disease (COVID-19) Situation Report-105 2020

Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention

Clinical management and infection control of SARS: Lessons learned

Hospital-acquired influenza infections detected by a surveillance system over six seasons, from

Hospital-acquired viral infection increases mortality in children with severe viral respiratory infection: Pediatric Critical Care Medicine

The Dose Response Multicentre Investigation on Fluid Assessment (DoReMIFA) in critically ill patients

Colonization of medical devices by staphylococci

Healthcare-associated infections, medical devices and biofilms: risk, tolerance and control

Strategies to Optimize the Supply of PPE and Equipment

COVID-19: All haemofiltration systems including machines and accessories -serious risks if users don't follow manufacturer instructions for set-up

Multidisciplinary Evaluation for Severity of Hazards Applied to Hemodialysis Devices: An Original Risk Analysis Method

Surveillance of device associated infections and mortality in a major intensive care unit in the Republic of Cyprus

Enforcement Policy for Non-Invasive Remote Monitoring Devices Used to Support Patient Monitoring During the Coronavirus Disease-2019 (COVID-19) Public Health Emergency

Remote Monitoring of Automated Peritoneal Dialysis Improves Personalization of Dialytic Prescription and Patient's Independence

Remote control improves quality of life in elderly pacemaker patients versus standard ambulatory-based follow-up

Bench-to-bedside review: Citrate for continuous renal replacement therapy, from science to practice

Nomenclature for renal replacement therapy and blood purification techniques in critically ill patients: practical applications

The Charta of Vicenza

The basics of respiratory mechanics: ventilator-derived parameters

Global Incidence and Mortality Trends due to Adverse Effects of Medical Treatment, 1990-2017: A Systematic Analysis from the Global Burden of Diseases, Injuries and Risk Factors Study

Remote monitoring and medical devices control in eHealth

Medical Devices and Medical Systems -Essential safety requirements for equipment comprising the patient-centric integrated clinical environment (ICE) -Part 1: General requirements and conceptual model

11073-10207-2017 -IEEE Health informatics--Point-of-care medical device communication Part 10207: Domain Information and Service Model for Service-Oriented Point-of-Care Medical Device Communication

Risks in the Application of Medical Devices: Human Factors in the Medical Environment

Nomenclature for renal replacement therapy in acute kidney injury: basic principles

Nomenclature for renal replacement therapies in chronic patients

The future of critical care: renal support in 2027

on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance

Factors to consider when using additional tubing with B. Braun Space TM and Outlook® large volume infusion pumps to increase the distance between the pump and the patient. BBraun COVID-19 Information n

Prismaflex Control Unit FA-2020-006 Safety Alert n

COVID-19: ensuring our medical equipment can meet the challenge

Ventilator Supply Mitigation Strategies: Letter to Health Care Providers

Not applicable

 healthcare-associated Infections (including respiratory viral and bacterial infections) are increasing especially in high-risk areas such as ICUs  the management of critically ill patients requires several and prolonged life-support devices (ventilators, extracorporeal circuits, infusion pumps) increasing the risk of crosscontamination by aerosol, infected organic fluids or direct contact  remote control of these devices, from a separated control-room, reduces unnecessary personnel biohazard exposure and contacts for both patients and healthcare workers  bidirectional communication with medical equipment allows for:1. prevent contamination of patients and medical staff by limiting the spread of infections 2. time and cost saving due to the reduced need of PPE 3. prescribe and administer a therapy with a strict monitoring of vital signs 4. facilitate decision making and timely interventions